- MorphoSys (MOR TH) +12%
- MorphoSys, Incyte: FDA Approves Monjuvi With Lenalidomide
-
Glaxo (GS7 TH) +3.2%
- GlaxoSmithKline PLC GSK Sanofi/GSK to supply EU with 300m COVID 19 doses
-
IAG (INR TH) +3.2%
- Discount EU Airlines May Save Summer, But Less-Rosy Winter Looms
- AMS (DQW1 TH) +3.2%
-
AstraZeneca (ZEG TH) +2.7%
- J&J, Astra Covid-19 Vaccines Have Upper Hand in Animal Tests
-
TOTAL SE (TOTB TH) +2.6%
- Total Upgraded, Eni Cut at Morgan Stanley on Dividend Outlooks
- Rolls-Royce (RRU TH) +2.5%
-
Siemens Healthineers (SHL TH) +2.4%
- Siemens Arm’s $16.4 Billion Varian Deal Opens Path to DAX
- Lanxess (LXS TH) -1.1%
- Lanxess Cut to Hold at SocGen; PT 48 euros
- SocGen (SGE TH) -1.2%
- SocGen Extends Losing Streak With Surprise $1.5 Billion Loss
- Aroundtown (AT1 TH) -2.1%
- Aroundtown Rated New Underweight at Morgan Stanley; PT 5 euros
-
MTU Aero (MTX TH) -2.3%
- MTU Aero Second Quarter Adjusted Ebit Misses Estimates
-
HSBC (HBC1 TH) -3.9%
- HSBC Warns of $13 Billion in Loan Losses After Profit Miss